Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy

23 Oct 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Function and Risk Factors
Share to MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24161319
DOI: 10.1016/j.jacc.2013.09.041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic CardiomyopathyPMID 24161319Read ↗

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersSemantic proximity Read ↗

A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathySemantic proximity Read ↗

Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathySemantic proximity Read ↗

Role of the microRNA-29 family in myocardial fibrosisSemantic proximity Read ↗

MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the ArtSemantic proximity Read ↗

MicroRNAs in cardiovascular diseaseSemantic proximity Read ↗

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.Semantic proximity Read ↗

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic CardiomyopathySemantic proximity Read ↗

Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.Semantic proximity Read ↗

Characterisation of circulating microRNA-21 levels in patients with hypertrophic cardiomyopathySemantic proximity Read ↗

Exosomal microRNA-29a mediates cardiac dysfunction and mitochondrial inactivity in obesity-related cardiomyopathySemantic proximity Read ↗

The microRNA in ventricular remodeling: the miR-30 familySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.